Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12...
Original Article: Biomarker for guiding prostate cancer treatment revealed
NEXT ARTICLE